Gees don't be swayed by me.
But when you can get exposure to some really good assets at a 40% discount...
Like you identified though, the fee structure is absolutely disgraceful.
I have been following one of their investments, Imugene for a very long time. In the Australian biotech scene, they are at the forefront of cancer treatment.
How long can you possibly justify keeping a fund going when it's trading at nearly half its NAV???
Thoughts, page-12
Add TEK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.71M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 13.0¢ | $9.712K | 74.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 879273 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 566323 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| TEK (ASX) Chart |